TABLE 1.
Study population characteristics
| Variablea | No. (%) of patients |
|---|---|
| Age (yr) | |
| 0-19 | 8 (7.55) |
| 20-39 | 17 (16.04) |
| 40-59 | 26 (24.53) |
| 60-79 | 44 (41.51) |
| 80+ | 11 (10.38) |
| Female sex | 52 (49.06) |
| Race | |
| White | 78 (73.58) |
| Black | 16 (15.09) |
| Other | 12 (11.32) |
| Hematologic malignancy | 17 (16.04) |
| Catheter removal | |
| No catheter | 13 (12.26) |
| No | 13 (12.26) |
| Yes | 80 (75.47) |
| APACHE III score | |
| 0-24 | 9 (8.49) |
| 25-49 | 24 (22.64) |
| 50-74 | 53 (50.00) |
| 75+ | 20 (18.87) |
| Acute renal failure | 27 (25.47) |
| Neutropenia (ANC, <500 cells/μl) | 6 (5.66) |
| Appropriate therapyb | |
| No | 0 (0.00) |
| Yes | 31 (29.25) |
| Evaluation not performed | 75 (70.75) |
| Total | 106 (100) |
a
APACHE, Acute Physiology and Chronic Health Evaluation; ANC, absolute neutrophil count.
b
The appropriateness of therapy was evaluated in 31 out of 106 cases (observations occurring on or after August 2006).